Results 21 to 30 of about 15,054 (69)

Fluoroquinolone prophylaxis does not increase risk of neuropathy in children with acute lymphoblastic leukemia

open access: yesCancer Medicine, 2020
Background Fluoroquinolone antibiotics are frequently utilized in pediatric oncology patients as prophylaxis or step‐down therapy following broad spectrum beta‐lactam therapy for febrile neutropenia.
Seth E. Karol   +10 more
doaj   +1 more source

MIXED HYALINE VASCULAR AND PLASMA CELL TYPE CASTLEMAN’S DISEASE: REPORT OF A CASE [PDF]

open access: yesActa Medica Iranica, 2006
Castleman’s disease (angiofollicular lymphoid hyperplasia) includes a heterogeneous group of lymphoproliferative disorders. The cause of this disease remains uncertain.
F. Asgarani   +4 more
doaj   +1 more source

Castle man disease: a case report and review of the literature

open access: yesThe Pan African Medical Journal, 2014
The Castleman disease (CD) is a rare disease of unknown etiology, characterized histologically by angiofollicular lymphoid hyperplasia. It comes in two forms, unicentric and multicentric.
Mounir Kettani   +6 more
doaj   +1 more source

Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: implications for combination therapy with antitumor antibodies

open access: yesJournal for ImmunoTherapy of Cancer, 2021
Background Full application of cytokines as oncoimmunotherapeutics requires identification of optimal regimens. Our initial effort with intravenous bolus recombinant human interleukin-15 (rhIL-15) was limited by postinfusional reactions.
Thomas A Waldmann   +11 more
doaj   +1 more source

The expression of MALAT1 long non-coding RNA is associated with good prognosis in mantle cell lymphoma

open access: yesScientific Reports
MALAT1 is a long non-coding RNA (lncRNA) with altered expression in many cancers but poorly studied in B-cell neoplasms like mantle cell lymphoma (MCL), a very aggressive B-cell lymphoma.
Elena María Fernández-Garnacho   +22 more
doaj   +1 more source

Haploidentical and MHC-identical cells exhibit broadly similar immune reconstitution kinetics, with some compartment-specific differences, following hematopoietic cell transplantation in a murine model of severe combined immunodeficiency

open access: yesFrontiers in Immunology
IntroductionImmune reconstitution following HLA-haploidentical hematopoietic cell transplantation (Haplo-HCT) is often delayed compared with HLA-identical transplantation, which frequently poses clinical challenges.
Isabel Hidalgo   +5 more
doaj   +1 more source

Oral manifestations leading to the diagnosis of acute lymphoblastic leukemia in a young girl

open access: yesJournal of Indian Society of Pedodontics and Preventive Dentistry, 2012
Background: oral complications may be leukemia′s first presentation. Aim: to present a case of a young girl with a swelling on the face that led to the diagnosis of acute lymphoblastic leukemia is reported. Results: a 10-year old anemic girl was referred
B A Silva   +4 more
doaj   +1 more source

A Rare Case of Primary Vulvar Diffuse Large B‐Cell Lymphoma: A Case Report

open access: yesClinical Case Reports
Primary vulvar diffuse large B‐cell lymphoma is a diagnostically challenging malignant tumor due to its low incidence and diverse clinical presentations. It has a good prognosis and is usually radio‐chemotherapy‐responsive.
M. Singh   +5 more
doaj   +1 more source

High rate of complete responses to immune checkpoint inhibitors in patients with relapsed or refractory Hodgkin lymphoma previously exposed to epigenetic therapy

open access: yesJournal of Hematology & Oncology, 2016
Options for patients with relapsed or refractory (R/R) classical Hodgkin lymphoma (cHL) after brentuximab vedotin (Bv) and autologous stem cell transplantation (ASCT) are limited.
Lorenzo Falchi   +8 more
doaj   +1 more source

Systems biology drug screening identifies statins as enhancers of current therapies in chronic lymphocytic leukemia

open access: yesScientific Reports, 2020
Chronic lymphocytic leukemia (CLL) is a B lymphoid malignancy highly dependent on the microenvironment. Despite new targeted therapies such as ibrutinib and venetoclax, disease progression and relapse remain an issue.
Neus Gimenez   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy